Literature DB >> 2044546

Electrophysiologic evaluation and outcome of patients with syncope of unknown origin.

T Muller1, D Roy, M Talajic, R Lemery, S Nattel, D Cassidy.   

Abstract

Electrophysiologic studies were performed in 134 patients (87 males, mean age 59 years) with unexplained syncope. Seventy-one patients had organic heart disease (ischaemic in 50). Electrophysiologic studies revealed conduction abnormalities and tachyarrhythmias that could account for syncope in 40 patients (30%). Thirty-seven (93%) of these patients received pacing or antiarrhythmic therapy compared with 23 (24%) of the remaining 94 patients who had a negative study and received empiric therapy (P less than 0.0001). Risk of having an abnormal electrophysiologic study was greater in patients with underlying heart disease (P less than 0.05). During a mean follow-up of 22 +/- 17 months, 26 patients (19%) either had recurrent syncope (22 patients) or died (four patients) suddenly. Men had a higher incidence of recurrent syncope than women (26% vs 6%, P less than 0.005). Other clinical characteristics, electrophysiologic findings, final diagnosis and therapy at discharge were not predictive of outcome. We conclude that (1) 19% of patients investigated for syncope will have a recurrent event, (2) female gender may be an independent predictor of favourable outcome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044546     DOI: 10.1093/oxfordjournals.eurheartj.a059859

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  Results of invasive electrophysiologic evaluation in 268 patients with unexplained syncope.

Authors:  Jiagao Lü; Zaiying Lu; Fredrik Voss; Wolfgang Schoels
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

2.  Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment.

Authors:  M Linzer; D T Gold; M Pontinen; G W Divine; A Felder; W B Brooks
Journal:  J Gen Intern Med       Date:  1994-04       Impact factor: 5.128

3.  Permanent pacing for cardioinhibitory malignant vasovagal syndrome.

Authors:  M E Petersen; R Chamberlain-Webber; A P Fitzpatrick; A Ingram; T Williams; R Sutton
Journal:  Br Heart J       Date:  1994-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.